Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew C Baker

Showing results (1-10 of 122) with videos related to

Pageof 13
Sort By:
Social Science & Medicine (1982)|February 2, 2025
Moving opportunistically: Interstate migration after medicaid expansionMatthew C Baker, Thomas Stratmann
Osteoarthritis and Cartilage|May 31, 2024
Repurposing drugs for the treatment of osteoarthritisWilson Kuswanto, Matthew C Baker
Medical Care Research and Review : MCRR|March 18, 2025
Hospital Entry Improves Quality: Evidence From Common Medical ConditionsMatthew C Baker, Thomas Stratmann
The Journal of Rheumatology|October 15, 2022
The Third Dose Is the Charm: Effective Cellular and Humoral Immune Responses to Third COVID-19 Vaccine Doses in Immunosuppressed NonrespondersWilson Kuswanto, Matthew C Baker
Medicine|September 22, 2020
Dual eligible patients are not the same: How social risk may impact quality measurement's ability to reduce inequitiesPhilip M Alberti, Matthew C Baker
The Lancet. Rheumatology|June 30, 2024
Annual trends in pain management modalities in patients with newly diagnosed autoimmune rheumatic diseases in the USA from 2007 to 2021: an administrative claims-based studyTitilola Falasinnu, Di Lu, Matthew C Baker
Chest|October 10, 2020
A Mortality Risk Score Model for Clinically Amyopathic Dermatomyositis-Associated Interstitial Lung Disease: Will It Have the Necessary "FLAIR" to Improve Clinical Outcomes?Matthew C Baker, Lorinda Chung, David F Fiorentino
Arthritis & Rheumatology (Hoboken, N.J.)|October 30, 2023
ReplyMatthew C Baker, Mark C Genovese, Konstantinos Alataris
Osteoarthritis and Cartilage|November 11, 2023
Genetic association between atopic disease and osteoarthritisMatthew C Baker, William H Robinson, Quinn Ostrom
Rheumatology (Oxford, England)|November 17, 2023
IL-6 receptor inhibition and risk of sarcoidosis: a Mendelian randomization studySizheng Steven Zhao, Matthew C Baker, James B Galloway
Pageof 13

Showing results (1-10 of 122) with videos related to

Sort By:
Pageof 13
Social Science & Medicine (1982)|February 2, 2025
Moving opportunistically: Interstate migration after medicaid expansionMatthew C Baker, Thomas Stratmann
Osteoarthritis and Cartilage|May 31, 2024
Repurposing drugs for the treatment of osteoarthritisWilson Kuswanto, Matthew C Baker
Medical Care Research and Review : MCRR|March 18, 2025
Hospital Entry Improves Quality: Evidence From Common Medical ConditionsMatthew C Baker, Thomas Stratmann
The Journal of Rheumatology|October 15, 2022
The Third Dose Is the Charm: Effective Cellular and Humoral Immune Responses to Third COVID-19 Vaccine Doses in Immunosuppressed NonrespondersWilson Kuswanto, Matthew C Baker
Medicine|September 22, 2020
Dual eligible patients are not the same: How social risk may impact quality measurement's ability to reduce inequitiesPhilip M Alberti, Matthew C Baker
The Lancet. Rheumatology|June 30, 2024
Annual trends in pain management modalities in patients with newly diagnosed autoimmune rheumatic diseases in the USA from 2007 to 2021: an administrative claims-based studyTitilola Falasinnu, Di Lu, Matthew C Baker
Chest|October 10, 2020
A Mortality Risk Score Model for Clinically Amyopathic Dermatomyositis-Associated Interstitial Lung Disease: Will It Have the Necessary "FLAIR" to Improve Clinical Outcomes?Matthew C Baker, Lorinda Chung, David F Fiorentino
Arthritis & Rheumatology (Hoboken, N.J.)|October 30, 2023
ReplyMatthew C Baker, Mark C Genovese, Konstantinos Alataris
Osteoarthritis and Cartilage|November 11, 2023
Genetic association between atopic disease and osteoarthritisMatthew C Baker, William H Robinson, Quinn Ostrom
Rheumatology (Oxford, England)|November 17, 2023
IL-6 receptor inhibition and risk of sarcoidosis: a Mendelian randomization studySizheng Steven Zhao, Matthew C Baker, James B Galloway
Pageof 13